Spix, Barbara; Butz, Elisabeth S.; Chen, Cheng-Chang; Rosato, Anna Scotto; Tang, Rachel; Jeridi, Aicha; Kudrina, Veronika 
ORCID: 0000-0002-3762-8673; Plesch, Eva; Wartenberg, Philipp; Arlt, Elisabeth; Briukhovetska, Daria; Ansari, Meshal 
ORCID: 0000-0002-8819-7965; Günsel, Gizem Günes; Conlon, Thomas M. 
ORCID: 0000-0002-4316-6612; Wyatt, Amanda 
ORCID: 0000-0003-1107-3857; Wetzel, Sandra; Teupser, Daniel; Holdt, Lesca M.; Ectors, Fabien 
ORCID: 0000-0003-2846-7019; Boekhoff, Ingrid; Boehm, Ulrich; García-Añoveros, Jaime 
ORCID: 0000-0001-6561-9048; Saftig, Paul 
ORCID: 0000-0003-2637-7052; Giera, Martin 
ORCID: 0000-0003-1684-1894; Kobold, Sebastian 
ORCID: 0000-0002-5612-4673; Schiller, Herbert B. 
ORCID: 0000-0001-9498-7034; Zierler, Susanna; Gudermann, Thomas; Wahl-Schott, Christian 
ORCID: 0000-0002-7514-2367; Bracher, Franz 
ORCID: 0000-0003-0009-8629; Yildirim, Ali Önder 
ORCID: 0000-0003-1969-480X; Biel, Martin 
ORCID: 0000-0002-9974-3052; Grimm, Christian 
ORCID: 0000-0002-0177-5559
  
(2022): 
Lung emphysema and impaired macrophage elastase clearance in mucolipin 3 deficient mice.
    Nature Communications, 13: 318.
    
     ISSN 2041-1723
  
  
  
Veröffentlichte Publikation
s41467-021-27860-x.pdf
			  
               
              
  
              Abstract
Lung emphysema and chronic bronchitis are the two most common causes of chronic obstructive pulmonary disease. Excess macrophage elastase MMP-12, which is predominantly secreted from alveolar macrophages, is known to mediate the development of lung injury and emphysema. Here, we discovered the endolysosomal cation channel mucolipin 3 (TRPML3) as a regulator of MMP-12 reuptake from broncho-alveolar fluid, driving in two independently generated Trpml3 −/− mouse models enlarged lung injury, which is further exacerbated after elastase or tobacco smoke treatment. Mechanistically, using a Trpml3 IRES-Cre/eR26- τ GFP reporter mouse model, transcriptomics, and endolysosomal patch-clamp experiments, we show that in the lung TRPML3 is almost exclusively expressed in alveolar macrophages, where its loss leads to defects in early endosomal trafficking and endocytosis of MMP-12. Our findings suggest that TRPML3 represents a key regulator of MMP-12 clearance by alveolar macrophages and may serve as therapeutic target for emphysema and chronic obstructive pulmonary disease.
| Dokumententyp: | Artikel (LMU) | 
|---|---|
| Organisationseinheit (Fakultäten): | 07 Medizin > Walther-Straub-Institut für Pharmakologie und Toxikologie | 
| DFG-Fachsystematik der Wissenschaftsbereiche: | Lebenswissenschaften | 
| Veröffentlichungsdatum: | 24. Okt 2022 13:24 | 
| Letzte Änderung: | 07. Dez 2023 12:15 | 
| URI: | https://oa-fund.ub.uni-muenchen.de/id/eprint/287 | 
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 491502892 | 
		
	![Publikation bearbeiten['Plugin/Screen:render_action_img_suffix' not defined] Publikation bearbeiten](/style/images/action_view.png)